-+ 0.00%
-+ 0.00%
-+ 0.00%

Novanta (NOVT) Rebound Puts Its Fair Value Narrative To The Test

Simply Wall St·09/05/2026 08:19:36
语音播报

Novanta (NOVT) is drawing investor attention after recent trading left the stock at a last close of $148.36. Returns have been mixed over different periods, and recent figures offer a fresh reference point for portfolio reviews.

Over the past year, Novanta has combined a 33.49% year-to-date share price return with a 27.79% 1-year total shareholder return. The weaker 3- and 5-year total shareholder returns suggest that recent momentum is improving after a softer longer-term period.

Compare Novanta's recent rebound with a hand picked group of companies by scanning the 19 high quality undiscovered gems that may be flying under most investors' radar.

Novanta now trades at a discount to analyst targets, yet its own fair value estimate points in a different direction. Is the recent rebound a sign that the market is too cautious, or not cautious enough?

Most Popular Narrative: 23.7% Undervalued

The most followed narrative on Novanta pegs fair value at $194.50, well above the last close of $148.36. That gap hinges on a specific view of how growth, margins and valuation will line up over the next few years.

The analysts have a consensus price target of $194.5 for Novanta based on their expectations of its future earnings growth, profit margins and other risk factors.

In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $1.7 billion, earnings will come to $168.2 million, and it would be trading on a PE ratio of 66.9x, assuming you use a discount rate of 9.0%.

Read the complete narrative.

Want to see the full playbook behind that $194.50 fair value for Novanta? The narrative leans on faster growth, fatter margins and a richer earnings multiple than many investors might expect. Curious which of those levers does the heavy lifting in this model and how sensitive the story is to small changes in the assumptions? The next section lays out the details that sit behind that headline number.

Result: Fair Value of $194.50 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the Novanta story can change quickly if acquisitions underperform or if ongoing trade disruptions and manufacturing shifts continue to pressure margins and organic growth.

Find out about the key risks to this Novanta narrative.

Another View On Novanta’s Valuation

The popular fair value for Novanta at $194.50 suggests the stock is 23.7% undervalued. The P/E picture tells a very different story. Novanta trades on a P/E of 90.8x, compared with a peer average of 56.8x and a fair ratio of 39.2x that the market could move toward. That gap points to meaningful valuation risk if sentiment or growth expectations cool, so which set of assumptions do you rely on more?

See what the numbers say about this price — find out in our valuation breakdown.

NasdaqGS:NOVT P/E Ratio as at Sep 2026
NasdaqGS:NOVT P/E Ratio as at Sep 2026

Next Steps

Mixed signals on Novanta's value can be confusing. Check the numbers, weigh the upside and downside, and then review the 2 key rewards and 1 important warning sign.

Looking for more ideas beyond Novanta?

If Novanta has you rethinking your portfolio, do not stop here. Use the tools available and keep pushing for ideas that match your goals and risk comfort.

  • Target potential mispricings by scanning a curated 47 high quality undervalued stocks that filters for companies with robust fundamentals and appealing valuations.
  • Strengthen your income stream by reviewing a focused 11 dividend fortresses that highlights higher-yield opportunities with an emphasis on sustainability.
  • Prioritise resilience by checking a 82 resilient stocks with low risk scores tailored to companies with steadier risk profiles that may help balance more volatile holdings.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.